Rchr
J-GLOBAL ID:201901008999541263   Update date: Aug. 21, 2024

Michiko Horiguchi

ホリグチ ミチコ | Michiko Horiguchi
Affiliation and department:
Research field  (4): Pharmaceuticals - chemistry and drug development ,  Biomedical engineering ,  Polymer materials ,  Pharmaceuticals - analytical and physicochemistry
Research keywords  (10): 創薬化学 ,  物理化学 ,  物理薬学 ,  細胞製剤設計学 ,  生体医工学 ,  ドラッグデリバリー ,  時間治療 ,  再生治療 ,  幹細胞 ,  がん
Research theme for competitive and other funds  (14):
  • 2023 - 2026 腎所属リンパ節を標的とするAKI-to-CKD transitionの新規治療戦略の構築
  • 2020 - 2024 幹細胞バンクの構築に向けた革新的な幹細胞製剤化技術の開発
  • 2019 - 2021 Regenerative therapy using stem cell sphere drug delivery system
  • 2016 - 2020 A Clinical study on activity of NAMPT and SIRT1 gene expression in neutropenia with cancer chemotherapy
  • 2015 - 2018 New stem cell therapy base on freeze drying
Show all
Papers (49):
  • Yuya Tsurudome, Yumi Takahata, Nao Morita, Soma Yamauchi, Takuya Iyoda, Michiko Horiguchi, Kentaro Ushijima. Increased SPARC in brain microvessels of ob/ob mice accelerates molecular transport into the brain accompany with albumin. Life sciences. 2024. 122990-122990
  • TSURUDOME, Yuya, FUNAKI, Tomoharu, HORIGUCHI, Michiko, USHIJIMA, Kentaro. Comparative dissolution study of original and generic furosemide tablets. 2024. 7. 39-43
  • Daniela Georgieva, Ning Wang, Angelo Taglialatela, Stepan Jerabek, Colleen R Reczek, Pei Xin Lim, Julie Sung, Qian Du, Michiko Horiguchi, Maria Jasin, et al. BRCA1 and 53BP1 regulate reprogramming efficiency by mediating DNA repair pathway choice at replication-associated double-strand breaks. Cell reports. 2024. 43. 4. 114006-114006
  • Marie Taniguchi, Sai Yasukochi, Wakaba Yamakawa, Yuya Tsurudome, Akito Tsuruta, Michiko Horiguchi, Kentaro Ushijima, Tomohiro Yamashita, Naoya Shindo, Akio Ojida, et al. Inhibition of tumor-derived CCL2 expression attenuates tactile allodynia in NCTC 2472 fibrosarcoma-inoculated mice. Molecular pharmacology. 2023
  • Yuya Tsurudome, Nao Morita, Michiko Horiguchi, Kentaro Ushijima. Decreased ZO1 expression causes loss of time-dependent tight junction function in the liver of ob/ob mice. Molecular biology reports. 2022. 49. 12. 11881-11890
more...
MISC (70):
  • 和田由喜世, 鶴留優也, 堀口道子, 牛島健太郎. 時計遺伝子BMAL1に着目した変形性関節症の疾患バイオマーカー探索. 日本薬学会九州山口支部大会講演要旨集(CD-ROM). 2023. 40th
  • 森田菜央, 鶴留優也, 堀口道子, 牛島健太郎. 糖尿病モデルob/obマウスにおける血管障害性合併症発症に寄与する原因因子の臓器間比較. 日本薬学会九州山口支部大会講演要旨集(CD-ROM). 2023. 40th
  • 堀口道子. Academia drug discovery of stem cell system. 日本薬学会年会要旨集(Web). 2023. 143rd
  • 鶴留優也, 堀口道子, 牛島健太郎. 高血糖時における肝細胞の細胞接着機能不全の要因解明. 日本臨床薬理学会学術総会抄録集(Web). 2022. 43rd
  • 鶴留優也, 森田菜央, 堀口道子, 牛島健太郎. Disruption of time-dependent tight junction function in the liver of ob/ob mice. 日本薬学会年会要旨集(Web). 2022. 142nd
more...
Patents (7):
more...
Education (1):
  • 2009 - 2012 Kyushu University Graduate School of Pharmaceutical Sciences
Professional career (1):
  • 博士(薬学) (九州大学)
Work history (5):
  • 2024/04 - 現在 山口東京理科大学 工学部 医薬工学科 准教授
  • 2024/04 - 現在 Sanyo Onoda City University Faculty of Pharmaceutical Sciences
  • 2019/04 - 2024/03 Tokyo University of Science,Yamaguchi
  • 2016/04 - 2019/03 Columbia University in the City of New York
  • 2012/04 - 2016/06 Tokyo University of Science Faculty of Pharmaceutical Sciences
Awards (11):
  • 2020/12 - 第41回 日本臨床薬理学会学術集会 優秀演題賞
  • 2018/07 - SHARE Cancer Support 2nd SHARE Study Workshop Certicate of Appreciation
  • 2017/04 - JMSA New York Life Science Forum 2017 JMSA Award 2017
  • 2015/05 - 第30回 日本薬剤学会年会 優秀発表賞
  • 2014/08 - 3rd Postgraduate Conference on Pharmaceutical Science 3rd iPoPs Certicate of Appreciation
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page